Certican 0.25mg Tablet

₨ 16,740

In stock
FormulaEverolimus (0.25mg)
Pack size60's
FormTablet
Therapeutic useTransplant rejection prevention and some cancers, including kidney, breast and neuroendocrine cancers
1 other brand with the same formulaCompare
Delivery in 2 to 3 working daysTo cities across Pakistan, delivery from ₨ 300
Cash on deliveryOr pay by bank transfer or card at checkout
Genuine productsFrom a DRAP-licensed pharmacy
Damaged or wrong item?We take it back. Read the return policy
Have a prescription? Upload it and our pharmacist will check your order.Questions about this product? WhatsApp 0336 3300001

About this product

Overview

Certican 0.25mg Tablet contains the active ingredient Everolimus and is prescribed for various medical conditions, primarily as an immunosuppressant medication to prevent organ rejection after transplantation. Everolimus belongs to a class of drugs called mammalian target of rapamycin (mTOR) inhibitors, which work by suppressing the immune system and inhibiting the growth of certain cells in the body.

Uses

Certican 0.25mg Tablet is used in combination with other immunosuppressive medications to prevent rejection of transplanted organs such as the kidney, liver, or heart. It may also be prescribed for the treatment of certain types of cancer, including advanced kidney cancer, breast cancer, and neuroendocrine tumors.

Administration

Certican 0.25mg Tablet is taken orally, typically once daily or as directed by a healthcare professional. The dosage may vary depending on the patient’s medical condition, response to treatment, and other medications they may be taking. It is essential to follow the prescribed dosage regimen and not to adjust the dose without consulting a healthcare provider.

Side Effects

Common side effects associated with Certican 0.25mg Tablet may include nausea, diarrhea, vomiting, mouth sores, loss of appetite, headache, dizziness, and fatigue. Some individuals may experience more severe side effects such as increased risk of infections, high blood sugar levels, high cholesterol levels, and changes in blood cell counts. It is important to report any unusual or bothersome symptoms to a healthcare provider.

Precautions

Before starting Certican 0.25mg Tablet, patients should inform their healthcare provider of any medical conditions they have, especially if they have a history of infections, diabetes, or liver or kidney problems. Everolimus may increase the risk of infections and may affect blood sugar and cholesterol levels, so regular monitoring is essential during treatment. Patients should also avoid exposure to sunlight and use sunscreen to prevent skin reactions.

When Not to Use

Certican 0.25mg Tablet should not be used in individuals who are allergic to Everolimus or any of its components. It is contraindicated in patients with active infections or with severe liver or kidney impairment. Everolimus may interact with certain medications, so patients should inform their healthcare provider of all the medications they are taking before starting treatment.

This information is for general awareness only. It does not replace advice from your doctor or pharmacist. Always read the leaflet and follow the directions you were given.

Other brands of Everolimus

These medicines also contain Everolimus, but in a different strength or pack. Do not switch to a different strength without asking your doctor.

MedicineManufacturerStrengthPrice
Certican 0.75mg TabletNovartis Pharma0.75mgRs 30,141.54

See all brands and prices on our Everolimus page.

Customer reviews

0 reviews
0
0
0
0
0

There are no reviews yet.

Be the first to review “Certican 0.25mg Tablet”